1220.3000 0.80 (0.07%)
NSE Aug 12, 2025 15:31 PM
Volume: 922.5K
 

1220.30
0.07%
Karvy
US business declines, margins outperform: DRL's revenues increased by 7% YoY to Rs 37.9 bn (lower than our estimates of Rs 38.9 bn) primarily due to de-growth in US business on account of higher pricing pressure due to incremental competition in some of the key products.
Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
More from Dr. Reddy's Laboratories Ltd.
Recommended